Itaconate is an effector of a Rab GTPase cell-autonomous host defense pathway against <i>Salmonella</i>.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 32703879.
- Also identified by DOI 10.1126/science.aaz1333 and PMC identifier 8020367.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
The guanosine triphosphatase (GTPase) Rab32 coordinates a cell-intrinsic host defense mechanism that restricts the replication of intravacuolar pathogens such as <i>Salmonella</i> Here, we show that this mechanism requires aconitate decarboxylase 1 (IRG1), which synthesizes itaconate, a metabolite with antimicrobial activity. We find that Rab32 interacts with IRG1 on <i>Salmonella</i> infection and facilitates the delivery of itaconate to the <i>Salmonella</i>-containing vacuole. Mice defective in IRG1 rescued the virulence defect of a <i>S. enterica</i> serovar Typhimurium mutant specifically defective in its ability to counter the Rab32 defense mechanism. These studies provide a link between a metabolite produced in the mitochondria after stimulation of innate immune receptors and a cell-autonomous defense mechanism that restricts the replication of an intracellular bacterial pathogen.
Medical subject headings
- Hydro-Lyases
- Salmonella Infections
- Salmonella enterica
- Salmonella typhimurium
- rab GTP-Binding Proteins